Pfizer Stops Phase 3 Trial of Lyrica Capsules CV in Neuropathic Pain Associated with HIV Neuropathy
Pfizer announced that it has stopped a Phase 3 clinical trail of Lyrica for patients with HIV neuropathy based on an interim analysis of the results. “The results of this study show the complexities of studying pain, particularly in a difficult-to-treat condition such as neuropathic pain associated with HIV neuropathy for which there are no …